Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy. [electronic resource]
- Expert review of anticancer therapy Jul 2007
- 919-43 p. digital
Publication Type: Journal Article; Review
1744-8328
10.1586/14737140.7.7.919 doi
Albumin-Bound Paclitaxel Albumins--adverse effects Antineoplastic Agents, Phytogenic--therapeutic use Breast Neoplasms--drug therapy Chemistry, Pharmaceutical Clinical Trials as Topic Humans Paclitaxel--adverse effects